4DKE image
Entry Detail
PDB ID:
4DKE
Title:
Crystal Structure of Human Interleukin-34 Bound to FAb1.1
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2012-02-03
Release Date:
2012-04-11
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Interleukin-34
Chain IDs:A, B
Chain Length:190
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:FAb1.1 Heavy Chain
Chain IDs:C (auth: H), E (auth: I)
Chain Length:230
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:FAb1.1 Light Chain
Chain IDs:D (auth: L), F (auth: M)
Chain Length:214
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation
Structural Basis for the Dual Recognition of Helical Cytokines IL-34 and CSF-1 by CSF-1R.
Structure 20 676 687 (2012)
PMID: 22483114 DOI: 10.1016/j.str.2012.02.010

Abstact

Lacking any discernible sequence similarity, interleukin-34 (IL-34) and colony stimulating factor 1 (CSF-1) signal through a common receptor CSF-1R on cells of mononuclear phagocyte lineage. Here, the crystal structure of dimeric IL-34 reveals a helical cytokine fold homologous to CSF-1, and we further show that the complex architecture of IL-34 bound to the N-terminal immunoglobulin domains of CSF-1R is similar to the CSF-1/CSF-1R assembly. However, unique conformational adaptations in the receptor domain geometry and intermolecular interface explain the cross-reactivity of CSF-1R for two such distantly related ligands. The docking adaptations of the IL-34 and CSF-1 quaternary complexes, when compared to the stem cell factor assembly, draw a common evolutionary theme for transmembrane signaling. In addition, the structure of IL-34 engaged by a Fab fragment reveals the mechanism of a neutralizing antibody that can help deconvolute IL-34 from CSF-1 biology, with implications for therapeutic intervention in diseases with myeloid pathogenic mechanisms.

Legend

Protein

Chemical

Disease

Primary Citation of related structures